“…Table 2 details fifteen series employing 2–7 fractions of radiotherapy where 12 month local control rates ranging between 49% and 96% are reported [ 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 ]. Studies were excluded from Table 2 if 12-month LC outcomes were not analysed, or if hypofractionated stereotactic radiotherapy (hfSRT) was performed postoperatively to the tumour cavity, with these patients not being separated in the analysis [ 58 , 59 , 60 , 61 , 62 , 63 , 64 ].…”